CRAI — CRA International, Inc.

CRA Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics:

• Revenue: Increased by 10.5% year-over-year to $201 million, marking the highest quarterly revenue in CRA's history.
• Non-GAAP EBITDA: $23.2 million, representing 11.5% of revenue. The EBITDA margin was impacted by a rise in forgivable loan amortization, which increased to 6.9% of revenue.
• Consultant Headcount: Rose by 2.5% year-over-year to 971, with improved consultant utilization at 77%.
• Cash and Debt: Ended the quarter with $32.5 million in cash and $192 million in borrowings, resulting in a net debt of $159.5 million. Total liquidity was $86.7 million after increasing the credit facility to $300 million.

2. Strategic Updates and Business Highlights:

• Broad-based growth across eight practices, with Energy, Finance, Forensic Services, and Life Sciences achieving double-digit revenue growth.
• Record performance in the Antitrust & Competition Economics practice, driven by increased M&A activity, which totaled $1.2 trillion globally, a 27% increase year-over-year.
• Continued investment in talent, with $62.3 million spent on talent acquisition and retention.
• Restructuring efforts led to a $2.6 million charge, expected to yield $5 million in annual cost savings.

3. Forward Guidance and Outlook:

• CRA reaffirmed its full-year financial guidance for fiscal 2026, citing strong market trends and a robust sales pipeline.
• Management expressed confidence in the demand for CRA's services, noting that the complexity of client needs continues to grow, which may enhance future revenue opportunities.

4. Bad News, Challenges, or Points of Concern:

• The increase in forgivable loan amortization could pressure profitability margins in the short term.
• The effective tax rate increased to 30.3%, up from 27.2% year-over-year, primarily due to higher non-deductible executive compensation.
• While the demand environment appears strong, management acknowledged potential risks from geopolitical and macroeconomic uncertainties that could impact business performance.

5. Notable Q&A Insights:

• CEO Paul Maleh emphasized that the current demand environment is the strongest he has seen, attributing it to a combination of internal capabilities and external market conditions.
• The Life Sciences practice showed significant growth, with European operations growing over 20%, indicating a positive trend in this segment.
• On pricing, CRA is implementing low to mid-single-digit rate increases, with expectations for more substantial contributions from these increases in the latter half of the year.
• The complexity of projects, particularly in M&A, has increased, leading to longer timelines and a greater need for CRA's expertise.

Overall, CRA's first-quarter performance reflects strong growth and operational efficiency, though management remains cautious about external risks and the impact of rising costs on profitability.